Safety Evaluation of EXPAREL (DepoFoam Bupivacaine) Administered by Repeated Subcutaneous Injection in Rabbits and Dogs: Species Comparison.
about
Safety of liposome extended-release bupivacaine for postoperative pain controlLiposomal Formulations in Clinical Use: An Updated Review.Multivesicular liposomal bupivacaine at the sciatic nerve.Pilot, randomized, placebo-controlled clinical field study to evaluate the effectiveness of bupivacaine liposome injectable suspension for the provision of post-surgical analgesia in dogs undergoing stifle surgery.Local toxicity from local anesthetic polymeric microparticlesLiposomal bupivacaine as a single-injection peripheral nerve block: a dose-response studyNeurotoxicity of perineural vs intraneural-extrafascicular injection of liposomal bupivacaine in the porcine model of sciatic nerve block.Current options for providing sustained analgesia to laboratory animals.Pharmacokinetic Profile and Tolerability of Liposomal Bupivacaine Following a Repeated Dose via Local Subcutaneous Infiltration in Healthy Volunteers.Newer drug delivery systems in anesthesia.Use of Liposomal Bupivacaine for Postoperative Analgesia in an Incisional Pain Model in Rats (Rattus norvegicus).An extended release local anaesthetic: potential for future use in veterinary surgical patients?Commentary on the clinical and preclinical dosage limits of interstitially administered magnetic fluids for therapeutic hyperthermia based on current practice and efficacy models.In vivo study of an extended release bupivacaine formulation following site-directed nerve injection
P2860
Q27691665-44295E08-96DF-4E92-8207-E1CC745966A7Q33850427-64146E60-06C3-4473-94D9-3784782A7487Q35115768-770B5834-043C-4CA3-B11C-05634C76F6ECQ36105319-295D9173-8924-4A8B-828A-19F8911D8DE2Q36711380-F603F626-B87C-4657-B178-C68C504C1C2BQ37255623-3F8C6CEE-220A-4621-8E63-E720DF742259Q37308937-F56611AD-14AB-4F8B-95B2-9BD3E3B3D8BBQ38252634-539CC6A5-9895-49A9-BDF7-97C31E0CC6BCQ38381795-33CAA967-18EF-4C53-9851-7EE208212218Q41081606-AD5B6B96-0C03-4C83-9C67-AEC6D07684F6Q41988337-95B6D6D0-7D18-4DA1-82B2-0BD28FA89D7EQ42682698-898E0C92-E15E-4AB1-A563-7CD0E81E3F16Q50090665-6178F467-AA6D-4E59-AE69-B3369FE35ABDQ57920702-8E83A740-BFD4-4074-9EC1-E9E659BA8D8A
P2860
Safety Evaluation of EXPAREL (DepoFoam Bupivacaine) Administered by Repeated Subcutaneous Injection in Rabbits and Dogs: Species Comparison.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Safety Evaluation of EXPAREL ( ...... and Dogs: Species Comparison.
@ast
Safety Evaluation of EXPAREL ( ...... and Dogs: Species Comparison.
@en
type
label
Safety Evaluation of EXPAREL ( ...... and Dogs: Species Comparison.
@ast
Safety Evaluation of EXPAREL ( ...... and Dogs: Species Comparison.
@en
prefLabel
Safety Evaluation of EXPAREL ( ...... and Dogs: Species Comparison.
@ast
Safety Evaluation of EXPAREL ( ...... and Dogs: Species Comparison.
@en
P2093
P2860
P356
P1476
Safety Evaluation of EXPAREL ( ...... and Dogs: Species Comparison.
@en
P2093
Abram N Brubaker
Brigitte M Richard
Douglas E Rickert
Keith G Nelson
Laura R Ott
Marlon C Rebelatto
Paul E Newton
Paul E Ross
Phaedra I Cole
P2860
P304
P356
10.1155/2011/467429
P577
2011-10-05T00:00:00Z